Lower urinary tract symptoms and erectile dysfunction; Links for diagnosis, management and treatment

International Journal of Impotence Research

Volumn 19, Issue 6, 2007, Pages 544-550

  Ponholzer, A ^a   Madersbacher, S ^a  

^a Donauspital ^*  (Austria)

Author keywords

ED; LUTS; Medical therapy; Pathogenesis; PDE 5; Therapy

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; DUTASTERIDE; FINASTERIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHODIESTERASE V INHIBITOR; RHO KINASE; SILDENAFIL; STEROID 5ALPHA REDUCTASE INHIBITOR; TAMSULOSIN; TERAZOSIN;

ATHEROSCLEROSIS; BLADDER; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; EJACULATION; EJACULATION DISORDER; ENDOTHELIUM; ENZYME ACTIVATION; ERECTILE DYSFUNCTION; GYNECOMASTIA; HUMAN; KIDNEY PELVIS; LIBIDO; LIBIDO DISORDER; LOWER URINARY TRACT SYMPTOM; MALE SEXUAL DYSFUNCTION; MINIMALLY INVASIVE CARDIAC SURGERY; MONOTHERAPY; NONHUMAN; PENIS; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; PROSTATECTOMY; RETROGRADE EJACULATION; REVIEW; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SIDE EFFECT; TRANSURETHRAL RESECTION; TREATMENT INDICATION; UROFLOWMETRY;

ADRENERGIC ALPHA-ANTAGONISTS; ENZYME INHIBITORS; ERECTILE DYSFUNCTION; HUMANS; MALE; OXIDOREDUCTASES; UROLOGIC DISEASES;

EID: 35348874421     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901578     Document Type: Review

References (37)

1. Lue TF. Erectile Dysfunction. N Engl J Med 2000; 342: 1802-1813.
2. Wespes E, Amar E, Hatzichristou D, Hatzimouratidis K, Montorsi F, Pryor J et al. EAU guidelines on erectile dysfunction. Eur Urol 2006; 49: 806-815.
3. Madersbacher S, Alivizatos G, Rioja Sanz C, Nordling J, Emberton M, Gravas S et al. EAU guidelines on benign prostatic hyperlpasia. Eur Urol 2004; 46: 547-554.
4. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol 1994; 151: 54-61.
5. Braun MH, Sommer F, Haupt G, Mathers MJ, Reifenrath B, Engelmann UH. Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical 'ging male' symptoms? Results of the 'cologne male survey'. Eur Urol 2003; 44: 588-594.
6. Nicolosi A, Glasser DB, Moreira ED, Villa M. Prevalence of erectile dysfunction and associated factors among men without concomitant diseases: a population study. Int J Impot Res 2003; 15: 253-257.
7. Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 2003; 44: 637-649.
8. Vallancien G, Emberton M, Harving N, van Moorselaar RJ, Alf-One Study Group. Sexual dysfunction in 1274 European men suffering from lower urinary tract symptoms. J Urol 2003; 169: 2257-2261.
9. Boyle P, Robertson C, Mazzetta C, Keech M. The association between lower urinary tract symptoms and erectile dysfunction in four centres; the UrEpik study. BJU Int 2003; 92: 719-725.
10. Hansen BL. Lower urinary tract symptoms and sexual function in both sexes. Eur Urol 2004; 46: 229-234.
11. Ponholzer A, Temml C, Obermayr R, Madersbacher S. Association between lower urinary tract symptoms and erectile dysfunction. Urology 2004; 64: 772-776.
12. Terai A, Ichioka K, Matsui Y, Yoshimura K. Association between lower urinary tract symptoms and erectile dysfunction. Urology 2004; 64: 132-136.
13. Shiri R, Hakkinen JT, Hakama M, Huhtala H, Auvinen A, Tammela TL et al. Effect of lower urinary tract symptoms on the incidence of erectile dysfunction. J Urol 2005; 174: 205-209.
14. Lukacs B, Leplege A, Thibault B, Jardin A. Prospective study of men with clinical benign prostatic hyperplasia treated with alfuzosin by general practitioners: 1-year results. Urology 1996; 48: 731-740.
15. McVary KT. Erectile dysfunction and lower urinary tract symptoms secondary to BPH. Eur Urol 2005; 47: 838-845.
16. Bing W, Chang S, Hypolite JA, DiSanto ME, Zderic SA, Rolf L. Obstruction-induced changes in urinary bladder smooth muscle contractility: a role for Rho kinase. Am J Physiol Renal Physiol 2003; 285: 990-997.
17. Rosen R, Giuliano F, Carson C. Sexual dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia. Eur Urol 2005; 47: 824-837.
18. McVary KT, McKenna KE. The relationship between erectile dysfunction and lower urinary tract symptoms: epidemiological, clinical and basic science evidence. Curr Urol Rep 2004; 5: 251-257.
19. Sairam K, Kulinskaya E, McNicholas TA, Boustead GB, Hanbury DC. Sildenafil improves lower urinary tract symptoms. BJU Int 2002; 90: 836-839.
20. Tarcan T, Azadzoi KM, Siroky MB, Goldstein I, Krane RJ. Age related erectile and voiding dysfunction: the role of arterial insufficiency. BJU 1998; 82: 26-33.
21. Ponholzer A, Temml C, Wehrberger C, Marszalek M, Madersbacher S. The association between LUTS and vascular risk factors in both sexes. Eur Urol 2006; 50: 581-586.
22. Medina JJ, Parra RO, Moore RG. Benign prostatic hyperplasia (the aging prostate). Med Clin North Am 1999; 83: 1213-1229.
23. Reilly CM, Stopper VS, Mills TM. Androgens modulate the alpha-adrenergic responsiveness of vascular smooth muscle in the corpus cavernosum. J Androl 1997; 18: 26-31.
24. McVary KT, Razzaq A, Lee C. Growth of the rat prostate gland is facilitated by the autonomic nervous system. Biol Reprod 1994; 51: 99-107.
25. McVary KT, Razzaq A, Lee C, Venegas MF, Rademaker A, McKenna KE. Growth of the rat prostate gland is facilitated by the autonomic nervous system. Biol reprod 1994; 51: 99-107.
26. Heidler S, Temml C, Broessner C, Mock K, Rauchenwald M, Madersbacher S et al. Is the metabolic syndrome an independent risk factor for ED? J Urol 2007; 177: 651-654.
27. Mulhall JP, Guhring P, Parker M, Hopps C. Assessment of the impact of sildenafil citrate on lower urinary tract symptoms in men with erectile dysfunction. J Sex Med 2006; 3: 662-667.
28. McVary KT, Monnig W, Camps JL, Young JM, Tseng LJ, van den Ende G. Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial. J Urol 2007; 177: 1071-1077.
29. AUA practice guidelines committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations. J Urol 2003; 170: 530-547.
30. Giuliano F. Impact of medical treatments for benign prostatic hyperplasia on sexual function. BJU Int 2006; 97(Suppl 2): 34-38.
31. Carson CC. Combination of phosphodiesterase-5 inhibitors and alpha-blockers in patients with benign prostatic hyperplasia: treatments of lower urinary tract symptoms, erectile dysfunction, or both? BJU Int 2006; 97(Suppl 2): 39-43.
32. van Moorselaar JRA, Hartung R, Emberton M, Harving N, Matzkin H, Elhilali M, for the Alf-one study group. Alfuzosin 10mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction. BJU Int 2005; 95: 603-608.
33. Roehrborn CG, Boyle P, Nickel JC, Hoefner K, Andriole G, ARIA3001 ARIA 3002 and ARIA 3003 Study Investigators. Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with BPH. Urology 2002; 60: 434-441.
34. McConnell JD, Roehrborn CG, Bautista OM, Andriole GL, Dixon CM, Kusek JW, for the MTOPS research group. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of BPH. N Engl J Med 2003; 349: 2387-2398.
35. Auersbach SM, Gittelman M, Mazzu A, Cihon F, Sundaresan P, White WB. Simultaneus administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia. Urology 2004; 64: 998-1004.
36. Giuliano F, Kaplan SA, Cabanis MJ, Astruc B. Hemodynamic interaction study between the alpha1-blocker alfuzosin and the phosphodiesterase-5 inhibitor tadalafil in middle-aged healthy male subjects. Urology 2006; 67: 1199-1204.
37. Wasson JH, Reda DJ, Bruskewitz RC, Elinson J, Keller AM, Henderson WG. Comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The veterans affairs cooperative study group on transurethral resection of the prostate. N Engl J Med 1995; 332: 75-79.